Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer

Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers

(2014) Hideo Shigeishi et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset

(2014) M. Veiseh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Small and Innovative Molecules as New Strategy to Revert MDR

(2014) Laura Zinzi et al.   Frontiers in Oncology

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection

(2013) Bing-sheng Sun et al.   ANNALS OF THORACIC SURGERY

Correlation of CD44v6 expression with ovarian cancer progression and recurrence

(2013) Jun Shi et al.   BMC CANCER

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives

(2013) Ziyad Binkhathlan et al.   CURRENT CANCER DRUG TARGETS

Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells

(2013) H Sui et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization

(2013) Willam Sterlacci et al.   Journal of Thoracic Oncology

The Roles of Hyaluronan/RHAMM/CD44 and Their Respective Interactions along the Insidious Pathways of Fibrosarcoma Progression

(2013) Dragana Nikitovic et al.   Biomed Research International

In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival

(2011) Alexandar Tzankov et al.   ANNALS OF HEMATOLOGY

Prognostic impact of CD168 expression in gastric cancer

(2011) Sumiya Ishigami et al.   BMC CANCER

Molecular characterization of kidney cancer

(2011) Andrew Chi et al.   CANCER

Vaccination Strategies in Lymphomas and Leukaemias

(2011) Katayoun Rezvani et al.   DRUGS

High transforming growth factor β expression represents an important prognostic parameter for surgically resected non–small cell lung cancer

(2011) William Sterlacci et al.   HUMAN PATHOLOGY

A Comprehensive Analysis of p16 Expression, Gene Status, and Promoter Hypermethylation In Surgically Resected Non-small Cell Lung Carcinomas

(2011) William Sterlacci et al.   Journal of Thoracic Oncology

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores

(2010) Alexandar Tzankov et al.   LEUKEMIA & LYMPHOMA

Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer

(2009) John M. Varlotto et al.   CANCER

Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling

(2009) Chi-Mou Liu et al.   CELL AND TISSUE RESEARCH

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas

(2009) Sabine Nagel et al.   EXPERIMENTAL HEMATOLOGY

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer

(2008) I Zlobec et al.   GUT

A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays

(2008) Colette Charpin et al.   INTERNATIONAL JOURNAL OF CANCER